Industry News
Summary of GLP-1 Drug Long-Acting Strateg…
To address the issue of a short half-life, various methods and strategies have been employed from two perspectives: enhancing tolerance to DPP-4 enzyme and reducing in vivo clearance.
Summary of ADCs in Clinical Phase 3
Summary of FDA approved ADCs and ADCs in clinical phase 3.
Classification of Anticoagulant Drugs
4 types of anticoagulants: Vitamin K antagonists (VKA), indirect thrombin inhibitors, direct thrombin inhibitors and factor Xa inhibitors. and Representative Drugs
Semaglutide Indication Opportunity: From …
On October 10, 2023, Novo Nordisk announced the early termination of a Phase 3 clinical trial of semaglutide for the treatment of patients with kidney injury and chronic kidney disease who ha…
Nectin-4 ADCs for Cancer Treatment
At present, only one Nectin-4 ADC drug, Padcev (enfortumab vedotin), has been approved for marketing for the second-line treatment of patients with uroepithelial cancer.
ADCs for HER2-Positive, HER2-Negative &am…
Here, we will analyze the three FDA approved ADCs for the HER2-positive, HER2-low, and HER2-negative breast cancers.
Sales of ADC Drugs From 2020 To 2023
According to the current trend, the total global ADC drug sales are expected to exceed $10 billion in 2023, which will become another important milestone in the ADC field. Below we present th…
Summary of Targeted Protein Degradation i…
Summary of targeted protein degradation, such as PROTAC and molecular glues in clinical trials.
Overview of New Targets For Anti-tumor Dr…
We will summarize the anti-tumor drug targets that have been newly discovered or have new indications recently.
The Role of Helper Lipids in Lipid Nanopa…
What are helper lipids? Whats the role of helper lipids in lipid nanoparticles?
sales@huatengusa.com
+86 0731 89916275